Yuvicyp-T Oral Drops contain Cyproheptadine (1.5 mg) and Tricholine Citrate (55 mg) as active ingredients, formulated to provide effective symptomatic relief in various clinical conditions. Cyproheptadine is an antihistaminic agent with antiserotonergic properties, widely used to alleviate allergic reactions such as rhinitis, urticaria, and pruritus by blocking histamine H1 receptors. Additionally, it exhibits appetite-stimulating effects, making it beneficial in managing conditions associated with anorexia and weight loss. Tricholine Citrate acts as a choline precursor that supports hepatic function and promotes lipid metabolism, thus aiding in the improvement of liver health and overall metabolic balance. The combination of these two agents in Yuvicyp-T Oral Drops offers a dual therapeutic approach by addressing allergic manifestations while enhancing appetite and liver function. This formulation is suitable for pediatric and adult patients requiring adjunctive treatment for allergy-related symptoms and appetite stimulation. Yuvicyp-T should be administered as directed by a healthcare professional, with dosage adjustments based on clinical response and patient tolerance. Caution is advised in patients with hepatic impairment, glaucoma, or epilepsy. Common adverse effects may include drowsiness, dry mouth, and gastrointestinal disturbances. Consultation with a physician is recommended before initiating therapy.